Sarepta Therapeutics, Inc. (BMV:SRPT)

Sarepta Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,482	1,902	1,243	933.01	701.89	540.1
Revenue Growth (YoY)	64.89%	52.97%	33.26%	32.93%	29.95%	41.82%
Cost of Revenue	516.59	321.5	151.9	140.7	97.76	64.04
Gross Profit	1,965	1,580	1,091	792.31	604.13	476.06
Selling, General & Admin	563.6	557.87	481.87	451.42	282.66	317.88
Research & Development	1,402	804.52	877.39	877.09	771.18	722.34
Other Operating Expenses	-	-	-	-	10	-
Operating Income	-0.93	218.08	-267.82	-536.2	-459.71	-564.16
Total Non-Operating Income (Expense)	-	-	489.33	125.44	102	63.07
Pretax Income	-24.13	260.77	-520.1	-689.96	-418.95	-553.07
Provision for Income Taxes	33.83	25.54	15.88	13.53	-0.17	1.06
Net Income	-57.96	235.24	-535.98	-703.49	-418.78	-554.13
Net Income to Common	-57.96	235.24	-535.98	-703.49	-418.78	-554.13
Shares Outstanding (Basic)	97	95	92	88	81	78
Shares Outstanding (Diluted)	109	108	92	88	81	78
Shares Change (YoY)	11.85%	16.75%	5.53%	7.75%	4.24%	5.90%
EPS (Basic)	-0.57	2.47	-5.80	-8.03	-5.15	-7.11
EPS (Diluted)	-0.81	2.34	-5.80	-8.03	-5.15	-7.11
Free Cash Flow	-531.55	-422.74	-577.1	-356.17	-481.66	25.26
Free Cash Flow Per Share	-4.86	-3.92	-6.25	-4.07	-5.93	0.32
Gross Margin	79.18%	83.10%	87.78%	84.92%	86.07%	88.14%
Operating Margin	-0.04%	11.47%	-21.54%	-57.47%	-65.50%	-104.46%
Profit Margin	-2.34%	12.37%	-43.11%	-75.40%	-59.66%	-102.60%
FCF Margin	-21.42%	-22.23%	-46.42%	-38.17%	-68.62%	4.68%
EBITDA	40.18	255.84	-223.43	-494.34	-421.69	-537.25
EBITDA Margin	1.62%	13.45%	-17.97%	-52.98%	-60.08%	-99.47%
EBIT	-0.93	218.08	-267.82	-536.2	-459.71	-564.16
EBIT Margin	-0.04%	11.47%	-21.54%	-57.47%	-65.50%	-104.46%
Effective Tax Rate	-140.17%	9.79%	-3.05%	-1.96%	0.04%	-0.19%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.